$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-Q Financial Statement

#000139681419000023 Filed on August 08, 2019

Income Statement

Concept	2019 Q2	2018 Q2	2018 Q1
Revenue	$102.6M	$84.11M	$74.61M
YoY Change	21.99%	18.57%	7.68%
Cost Of Revenue	$25.20M	$20.92M	$22.89M
YoY Change	20.49%	-12.16%	-6.9%
Gross Profit	$77.40M	$63.19M	$51.72M
YoY Change	22.49%	34.1%	15.7%
Gross Profit Margin	75.44%	75.13%	69.33%
Selling, General & Admin	$49.13M	$44.25M	$44.19M
YoY Change	11.02%	11.88%	4.92%
% of Gross Profit	63.47%	70.02%	85.44%
Research & Development	$17.83M	$12.24M	$14.38M
YoY Change	45.66%	-35.09%	-13.55%
% of Gross Profit	23.03%	19.37%	27.8%
Depreciation & Amortization	$3.500M	$2.800M	$2.762M
YoY Change	25.0%	-24.32%	-11.02%
% of Gross Profit	4.52%	4.43%	5.34%
Operating Expenses	$97.33M	$77.57M	$81.54M
YoY Change	25.48%	-10.55%	-2.15%
Operating Profit	$5.275M	$6.541M	-$6.937M
YoY Change	-19.35%	-141.45%	-50.63%
Interest Expense	$5.878M	$5.397M	$5.157M
YoY Change	8.91%	3.27%	99.19%
% of Operating Profit	111.43%	82.51%
Other Income/Expense, Net	-$4.148M	-$3.942M	-$3.708M
YoY Change	5.23%	0.23%	-35.91%
Pretax Income	$1.127M	$2.599M	-$10.65M
YoY Change	-56.64%	-113.18%	-46.33%
Income Tax	-$1.600M	$35.00K	$35.00K
% Of Pretax Income	-141.97%	1.35%
Net Earnings	$2.730M	$2.564M	-$10.68M
YoY Change	6.47%	-112.99%	-46.24%
Net Earnings / Revenue	2.66%	3.05%	-14.32%
Basic Earnings Per Share	$0.07	$0.06	-$0.26
Diluted Earnings Per Share	$0.06	$0.06	-$262.9K
COMMON SHARES
Basic Shares Outstanding	41.38M shares	40.80M shares	40.71M shares
Diluted Shares Outstanding	42.35M shares	41.69M shares

Balance Sheet

Concept	2019 Q2	2018 Q2	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$292.2M	$371.3M	$339.8M
YoY Change	-21.3%	-2.9%	-11.44%
Cash & Equivalents	$59.74M	$116.9M	$41.56M
Short-Term Investments	$232.5M	$254.5M	$298.2M
Other Short-Term Assets	$8.500M	$6.000M	$7.700M
YoY Change	41.67%	-20.0%	22.22%
Inventory	$52.70M	$42.05M	$40.04M
Prepaid Expenses
Receivables	$41.15M	$35.64M	$31.20M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$394.6M	$455.1M	$418.7M
YoY Change	-13.28%	0.9%	-6.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$105.5M	$111.3M	$109.2M
YoY Change	-5.2%	7.78%	6.49%
Goodwill	$100.5M	$59.91M	$57.49M
YoY Change	67.81%	17.61%	17.74%
Intangibles	$108.3M
YoY Change
Long-Term Investments	$42.40M	$15.70M	$35.80M
YoY Change	170.06%
Other Assets		$692.0K	$759.0K
YoY Change		20.98%	26.92%
Total Long-Term Assets	$393.2M	$187.6M	$203.3M
YoY Change	109.58%	21.24%	33.75%
TOTAL ASSETS
Total Short-Term Assets	$394.6M	$455.1M	$418.7M
Total Long-Term Assets	$393.2M	$187.6M	$203.3M
Total Assets	$787.8M	$642.7M	$622.0M
YoY Change	22.59%	6.1%	3.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.35M	$14.26M	$14.91M
YoY Change	-6.4%	37.22%	59.11%
Accrued Expenses	$51.91M	$38.43M	$33.02M
YoY Change	35.05%	-17.8%	-5.4%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$300.0K	$300.0K
YoY Change	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$83.00M	$53.02M	$48.37M
YoY Change	56.54%	-7.8%	5.96%
LONG-TERM LIABILITIES
Long-Term Debt	$298.2M	$283.3M	$279.7M
YoY Change	5.26%	5.2%	5.15%
Other Long-Term Liabilities	$8.993M	$15.89M	$15.46M
YoY Change	-43.39%	-11.05%	49.66%
Total Long-Term Liabilities	$8.993M	$15.89M	$15.46M
YoY Change	-43.39%	-11.05%	49.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$83.00M	$53.02M	$48.37M
Total Long-Term Liabilities	$8.993M	$15.89M	$15.46M
Total Liabilities	$446.2M	$352.2M	$343.5M
YoY Change	26.7%	2.17%	4.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$388.4M	-$395.9M	-$398.5M
YoY Change	-1.88%	2.52%	8.75%
Common Stock	$42.00K	$41.00K	$41.00K
YoY Change	2.44%	2.5%	2.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	0.000 shares	0.000 shares	0.000 shares
Shareholders Equity	$341.7M	$290.5M	$278.5M
YoY Change
Total Liabilities & Shareholders Equity	$787.8M	$642.7M	$622.0M
YoY Change	22.59%	6.1%	3.68%

Cashflow Statement

Concept	2019 Q2	2018 Q2	2018 Q1
OPERATING ACTIVITIES
Net Income	$2.730M	$2.564M	-$10.68M
YoY Change	6.47%	-112.99%	-46.24%
Depreciation, Depletion And Amortization	$3.500M	$2.800M	$2.762M
YoY Change	25.0%	-24.32%	-11.02%
Cash From Operating Activities	$22.76M	$13.71M	-$2.690M
YoY Change	66.01%	275.62%	-27000.0%
INVESTING ACTIVITIES
Capital Expenditures	-$2.050M	-$2.640M	$5.184M
YoY Change	-22.35%	-48.74%	43.36%
Acquisitions
YoY Change
Other Investing Activities	-$179.8M	$62.21M	-$5.110M
YoY Change	-388.94%	-211.09%	-96.36%
Cash From Investing Activities	-$181.8M	$59.57M	-$10.29M
YoY Change	-405.19%	-197.42%	-92.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.740M	2.020M	$419.0K
YoY Change	85.15%	-13.3%	-99.81%
NET CHANGE
Cash From Operating Activities	22.76M	13.71M	-2.690M
Cash From Investing Activities	-181.8M	59.57M	-10.29M
Cash From Financing Activities	3.740M	2.020M	$419.0K
Net Change In Cash	-155.3M	75.30M	$419.0K
YoY Change	-306.24%	-236.49%	-99.81%
FREE CASH FLOW
Cash From Operating Activities	$22.76M	$13.71M	-$2.690M
Capital Expenditures	-$2.050M	-$2.640M	$5.184M
Free Cash Flow	$24.81M	$16.35M	-$7.874M
YoY Change	51.74%	85.8%	118.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1800000	USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41222799	shares
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41606082	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41222799	shares
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41606082	shares
	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	100000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2019Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2019-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35060
	dei	Entity Registrant Name EntityRegistrantName	PACIRA BIOSCIENCES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	51-0619477
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5 Sylvan Way, Suite 300
	dei	Entity Address City Or Town EntityAddressCityOrTown	Parsippany
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07054
	dei	City Area Code CityAreaCode	973
	dei	Local Phone Number LocalPhoneNumber	254-3560
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	PCRX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2019Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41635099	shares
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59737000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132526000	USD
CY2019Q2	us-gaap	Short Term Investments ShortTermInvestments	232502000	USD
CY2018Q4	us-gaap	Short Term Investments ShortTermInvestments	250928000	USD
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	41147000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	38000000	USD
CY2019Q2	us-gaap	Inventory Net InventoryNet	52697000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	48569000	USD
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8526000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7946000	USD
CY2019Q2	us-gaap	Assets Current AssetsCurrent	394609000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	477969000	USD
CY2019Q2	us-gaap	Long Term Investments LongTermInvestments	25362000	USD
CY2018Q4	us-gaap	Long Term Investments LongTermInvestments	25871000	USD
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	105492000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	108670000	USD
CY2019Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	36494000	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2019Q2	us-gaap	Goodwill Goodwill	100538000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	62040000	USD
CY2019Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	108320000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	USD
CY2019Q2	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	17028000	USD
CY2018Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	14803000	USD
CY2019Q2	us-gaap	Assets Assets	787843000	USD
CY2018Q4	us-gaap	Assets Assets	689353000	USD
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	13347000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14368000	USD
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	51907000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	45865000	USD
CY2019Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6172000	USD
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2019Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2018Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	338000	USD
CY2019Q2	pcrx	Contingent Consideration Current ContingentConsiderationCurrent	11500000	USD
CY2018Q4	pcrx	Contingent Consideration Current ContingentConsiderationCurrent	0	USD
CY2019Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	78000	USD
CY2018Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	90000	USD
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	83004000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	60661000	USD
CY2019Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	298185000	USD
CY2018Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	290592000	USD
CY2019Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	39041000	USD
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2019Q2	pcrx	Contingent Consideration Noncurrent ContingentConsiderationNoncurrent	16970000	USD
CY2018Q4	pcrx	Contingent Consideration Noncurrent ContingentConsiderationNoncurrent	0	USD
CY2019Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8993000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16874000	USD
CY2019Q2	us-gaap	Liabilities Liabilities	446193000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	368127000	USD
CY2019Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	42000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	41000	USD
CY2019Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	729531000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	709691000	USD
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-388423000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-388226000	USD
CY2019Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	500000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-280000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	341650000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	321226000	USD
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	787843000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	689353000	USD
CY2019Q2	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	0	USD
CY2018Q2	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	3000000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	0	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	3000000	USD
CY2019Q2	us-gaap	Revenues Revenues	102604000	USD
CY2018Q2	us-gaap	Revenues Revenues	84107000	USD
	us-gaap	Revenues Revenues	193917000	USD
	us-gaap	Revenues Revenues	158714000	USD
CY2019Q2	us-gaap	Cost Of Revenue CostOfRevenue	25201000	USD
CY2018Q2	us-gaap	Cost Of Revenue CostOfRevenue	20916000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	52505000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	43801000	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17827000	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12239000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32210000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26617000	USD
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	49126000	USD
CY2018Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	44249000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	96431000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	88439000	USD
CY2019Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1770000	USD
CY2018Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1770000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2019Q2	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-3405000	USD
CY2018Q2	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-162000	USD
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-4647000	USD
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-252000	USD
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	97329000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	77566000	USD
	us-gaap	Operating Expenses OperatingExpenses	187563000	USD
	us-gaap	Operating Expenses OperatingExpenses	159109000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	5275000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	6541000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	6354000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-395000	USD
CY2019Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1817000	USD
CY2018Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1533000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3973000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2906000	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	5878000	USD
CY2018Q2	us-gaap	Interest Expense InterestExpense	5397000	USD
	us-gaap	Interest Expense InterestExpense	11691000	USD
	us-gaap	Interest Expense InterestExpense	10553000	USD
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-87000	USD
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-78000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-26000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4000	USD
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4148000	USD
CY2018Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3942000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7744000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7651000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1127000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2599000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1390000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8046000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1603000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	35000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1349000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	70000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	2730000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	2564000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-41000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8116000	USD
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41384000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40796000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41312000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40751000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42345000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41694000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41312000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40751000	shares
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	2730000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	2564000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-41000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8116000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	318000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	356000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	780000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-91000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	780000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-91000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	318000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	356000	USD
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3048000	USD
CY2018Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2920000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	739000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8207000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	327519000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2029000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1270000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7783000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	318000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	2730000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	341650000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	278521000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	0	USD
CY2018Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1073000	USD
CY2018Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2018Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	952000	USD
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7047000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	356000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	2564000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	290513000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	321226000	USD
CY2019Q2	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-156000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3586000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1270000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15217000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	780000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-41000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	341650000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	279483000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1492000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	952000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15432000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-91000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8116000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	290513000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-41000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8116000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8881000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5610000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	844000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	786000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6749000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6283000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-157000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-10000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	15217000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	15432000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2141000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3640000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2519000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	642000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1163000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-102000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1321000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2826000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1844000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2303000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-245000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	325000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	26262000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	11021000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	118683000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4070000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7818000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	141960000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	182749000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	163017000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	244562000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	0	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	4715000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1622000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-103318000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	49280000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3568000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1492000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	1270000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	952000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	338000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	233000	USD
	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4267000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2444000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-72789000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	62745000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132526000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54126000	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59737000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	116871000	USD
	us-gaap	Interest Paid InterestPaid	4102000	USD
	us-gaap	Interest Paid InterestPaid	4102000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	490000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	146000	USD
	pcrx	Increase Decrease In Contingent Consideration IncreaseDecreaseInContingentConsideration	28470000	USD
	pcrx	Increase Decrease In Contingent Consideration IncreaseDecreaseInContingentConsideration	0	USD
	pcrx	Increase Decreasein Accrued Fixed Assets IncreaseDecreaseinAccruedFixedAssets	682000	USD
	pcrx	Increase Decreasein Accrued Fixed Assets IncreaseDecreaseinAccruedFixedAssets	-2032000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	101824000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	80717000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	192730000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	155004000	USD
CY2019Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19014000	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19193000	USD
CY2019Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	10983000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9711000	USD
CY2019Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	22700000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	19665000	USD
CY2019Q2	us-gaap	Inventory Net InventoryNet	52697000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	48569000	USD
CY2019Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	174138000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	170228000	USD
CY2019Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	68646000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	61558000	USD
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	105492000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	108670000	USD
CY2019Q2	us-gaap	Depreciation Depreciation	3500000	USD
CY2018Q2	us-gaap	Depreciation Depreciation	2800000	USD
CY2018Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	200000	USD
	us-gaap	Depreciation Depreciation	7100000	USD
	us-gaap	Depreciation Depreciation	5600000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	600000	USD
CY2019Q2	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	63400000	USD
CY2018Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	64600000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P4Y
CY2019Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1516000	USD
CY2018Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1600000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	2959000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	3090000	USD
CY2019Q2	us-gaap	Variable Lease Cost VariableLeaseCost	449000	USD
CY2018Q2	us-gaap	Variable Lease Cost VariableLeaseCost	408000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	829000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	810000	USD
CY2019Q2	us-gaap	Lease Cost LeaseCost	1965000	USD
CY2018Q2	us-gaap	Lease Cost LeaseCost	2008000	USD
	us-gaap	Lease Cost LeaseCost	3788000	USD
	us-gaap	Lease Cost LeaseCost	3900000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	3121000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	38419000	USD
CY2019Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y9M7D
CY2019Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0762
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	4166000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7662000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5359000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5486000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5616000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	37208000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	65497000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	20284000	USD
CY2019Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	45213000	USD
CY2019Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Remainder Of Fiscal Year LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear	124000	USD
CY2019Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Two LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo	2530000	USD
CY2019Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Three LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree	4797000	USD
CY2019Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Four LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour	4937000	USD
CY2019Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Five LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFive	5081000	USD
CY2019Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due After Year Five LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFive	35848000	USD
CY2019Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability LesseeOperatingLeaseLeaseNotYetCommencedLiability	53317000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	8140000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7621000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	5295000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	5417000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	5543000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	14329000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	46345000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	62040000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	38498000	USD
CY2019Q2	us-gaap	Goodwill Goodwill	100538000	USD
CY2019Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	110090000	USD
CY2019Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1770000	USD
CY2019Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	108320000	USD
CY2019Q2	us-gaap	Share Price SharePrice	43.49
CY2018Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	14100000	USD
CY2019Q2	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	1600000	USD
	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2017	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	USD
CY2019Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1800000	USD
CY2018Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2019Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3900000	USD
CY2019Q2	pcrx	Finite Lived Intangible Assets Amortization Expense Annual Amount From2020 To2032 FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountFrom2020To2032	7900000	USD
CY2019Q2	pcrx	Finite Lived Intangible Assets Amortization Expense Annual Amount In2033 FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountIn2033	2200000	USD
	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
CY2019Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	300000	USD
CY2019Q1	pcrx	Repaymentof Conversion Premium RepaymentofConversionPremium	200000	USD
CY2019Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
CY2018Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3000000	shares
CY2019Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7783000	USD
CY2018Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7047000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15217000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15432000	USD
CY2019Q2	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	5322000	USD
CY2018Q2	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	4827000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	10252000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	11182000	USD
CY2019Q2	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	56000	USD
CY2018Q2	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	202000	USD
	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	247000	USD
	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	241000	USD
CY2019Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	2204000	USD
CY2018Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	1819000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	4311000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	3609000	USD
CY2019Q2	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	201000	USD
CY2018Q2	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	199000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	407000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	400000	USD
CY2019Q2	us-gaap	Share Based Compensation ShareBasedCompensation	7783000	USD
CY2018Q2	us-gaap	Share Based Compensation ShareBasedCompensation	7047000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	15217000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	15432000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	21.08
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	35766	shares
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	2730000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	2564000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-41000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8116000	USD
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41384000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40796000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41312000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40751000	shares
CY2019Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	810000	shares
CY2018Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	807000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2019Q2	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	148000	shares
CY2018Q2	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	87000	shares
	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	0	shares
	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	0	shares
CY2019Q2	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	3000	shares
CY2018Q2	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	4000	shares
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42345000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41694000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41312000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40751000	shares
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.07
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.06
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.00
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2019Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4616000	shares
CY2018Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4290000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6538000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5610000	shares
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	3760000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	592000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	5580000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-9221000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2633000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2007000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-6970000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1175000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1127000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2599000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1390000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8046000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1600000	USD
CY2018Q2	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1300000	USD
	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
CY2019Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1800000	USD
CY2019Q2	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	100000	USD
CY2018Q2	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	200000	USD
	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	300000	USD
CY2018Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	0	USD
CY2018Q4	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	1970000	USD
CY2018Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	282000	USD
CY2018Q4	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	2252000	USD
	us-gaap	Severance Costs1 SeveranceCosts1	390000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	193000	USD
	us-gaap	Costs Incurred Asset Retirement Obligation Incurred CostsIncurredAssetRetirementObligationIncurred	56000	USD
	us-gaap	Payments For Postemployment Benefits PaymentsForPostemploymentBenefits	144000	USD
	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	156000	USD
	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	300000	USD
	us-gaap	Other Restructuring Costs OtherRestructuringCosts	193000	USD
	us-gaap	Disposal Group Including Discontinued Operation Other Expense DisposalGroupIncludingDiscontinuedOperationOtherExpense	193000	USD
	pcrx	Lease Cost Reclassification LeaseCostReclassification	-1970000	USD
	pcrx	Asset Retirement Obligation Reclassification AssetRetirementObligationReclassification	455000	USD
	us-gaap	Business Exit Costs1 BusinessExitCosts1	-1515000	USD
CY2019Q2	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	246000	USD
CY2019Q2	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	0	USD
CY2019Q2	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	637000	USD
CY2019Q2	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	883000	USD

Files In Submission

Name	View Source	Status
0001396814-19-000023-index-headers.html	Edgar Link	pending
0001396814-19-000023-index.html	Edgar Link	pending
0001396814-19-000023.txt	Edgar Link	pending
0001396814-19-000023-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pacirabiosciencesa04.jpg	Edgar Link	pending
pcrx-20190630.xsd	Edgar Link	pending
pcrx-20190630_cal.xml	Edgar Link	unprocessable
pcrx-20190630_def.xml	Edgar Link	unprocessable
pcrx-20190630_lab.xml	Edgar Link	unprocessable
pcrx-20190630_pre.xml	Edgar Link	unprocessable
pcrx-6302019x10xq.htm	Edgar Link	pending
pcrx-6302019x10xq_htm.xml	Edgar Link	completed
pcrx-6302019xex101.htm	Edgar Link	pending
pcrx-6302019xex311.htm	Edgar Link	pending
pcrx-6302019xex312.htm	Edgar Link	pending
pcrx-6302019xex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2019 Q2 Form 10-Q Financial Statement

#000139681419000023 Filed on August 08, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2019 Q2 Form 10-Q Financial Statement

#000139681419000023 Filed on August 08, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx